Literature DB >> 22662757

Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients.

Thomas Bénet1, Nicolas Voirin, Marie-Christine Nicolle, Stephane Picot, Mauricette Michallet, Philippe Vanhems.   

Abstract

The duration of the incubation of invasive aspergillosis (IA) remains unknown. The objective of this investigation was to estimate the time interval between aplasia onset and that of IA symptoms in acute myeloid leukemia (AML) patients. A single-centre prospective survey (2004-2009) included all patients with AML and probable/proven IA. Parametric survival models were fitted to the distribution of the time intervals between aplasia onset and IA. Overall, 53 patients had IA after aplasia, with the median observed time interval between the two being 15 days. Based on log-normal distribution, the median estimated IA incubation period was 14.6 days (95% CI; 12.8-16.5 days).

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22662757     DOI： 10.3109/13693786.2012.687462

Source DB:  PubMed          Journal:  Med Mycol        ISSN： 1369-3786            Impact factor:   4.076


  6 in total

1.  Prospective CYP2C19-Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations.

Authors:  J Kevin Hicks; Rod E Quilitz; Rami S Komrokji; Timothy E Kubal; Jeffrey E Lancet; Yanina Pasikhova; Dahui Qin; Wonhee So; Gisela Caceres; Kerry Kelly; Yasmina S Salchert; Kevin Shahbazian; Farnoosh Abbas-Aghababazadeh; Brooke L Fridley; Ana P Velez; Howard L McLeod; John N Greene
Journal:  Clin Pharmacol Ther       Date:  2019-11-01       Impact factor: 6.875

Review 2.  Point-of-critical-care diagnostics for sepsis enabled by multiplexed micro and nanosensing technologies.

Authors:  Brandon K Ashley; Umer Hassan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-03-01

3.  Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study.

Authors:  Sophie Tiphaine Loeffert; Elise Melloul; Cédric Dananché; Laetitia Hénaff; Thomas Bénet; Pierre Cassier; Damien Dupont; Jacques Guillot; Françoise Botterel; Martine Wallon; Marie-Paule Gustin; Philippe Vanhems
Journal:  BMJ Open       Date:  2017-11-25       Impact factor: 2.692

4.  Development of Aspergillosis in a cohort of non-neutropenic, non-transplant patients colonised by Aspergillus spp.

Authors:  José Barberán; Francisco-Javier García-Pérez; Victoria Villena; Alberto Fernández-Villar; Eduardo Malmierca; Cristina Salas; María-José Giménez; Juan-José Granizo; Lorenzo Aguilar
Journal:  BMC Infect Dis       Date:  2017-01-06       Impact factor: 3.090

5.  Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.

Authors:  Joung Ha Park; Seung Hee Ryu; Jeong Young Lee; Hyeon Jeong Kim; Sun Hee Kwak; Jiwon Jung; Jina Lee; Heungsup Sung; Sung-Han Kim
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-29       Impact factor: 4.887

Review 6.  Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Authors:  Jeffrey D Jenks; Stephen A Rawlings; Carol Garcia-Vidal; Philipp Koehler; Toine Mercier; Juergen Prattes; Cornelia Lass-Flörl; M Teresa Martin-Gomez; Dieter Buchheidt; Livio Pagano; Jean-Pierre Gangneux; Frank L van de Veerdonk; Mihai G Netea; Agostinho Carvalho; Martin Hoenigl
Journal:  J Fungi (Basel)       Date:  2019-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.